Sponsor:
UCLA
Code:
NCT06940323
Conditions
Multiple Sclerosis
Clinically Isolated Syndrome
NMOSD
Myasthenia Gravis
Eligibility Criteria
Sex: Female
Age: 18 - 64
Healthy Volunteers: Accepted
Brief summary:
Conditions
Multiple Sclerosis
Clinically Isolated Syndrome
NMOSD
Myasthenia Gravis
Study ID
NCT06940323
Start date
Mar 21, 2017
Status verified date
Aug, 2026
Completion date
Jun, 2035
Anticipated
Primary completion date
Jun, 2030
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 64
Healthy Volunteers: Accepted
Enrollment
250 participants
Anticipated
Arms
Healthy Controls
Multiple sclerosis (MS)
Clinically isolated syndrome (CIS)
Neuromyelitis optica spectrum disorder (NMOSD)
Myasthenia gravis
Primary outcome measure
Central contacts
Locations
University of California-San Francisco
Recruiting
San Francisco, California, United States, 94158
Contacts
Principal Investigator:
Riley Bove
Sponsor
University of California, San Francisco
Last update posted
Aug 11, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-24. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-08-11. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.